130 related articles for article (PubMed ID: 21469498)
1. ALERT: mix-ups between conventional and lipid formulations of amphotericin B can be extremely dangerous.
Koczmara C; Richardson H; Hyland S; Lee CS; Hillebrand N
Dynamics; 2011; 22(1):24-6. PubMed ID: 21469498
[TBL] [Abstract][Full Text] [Related]
2. Injectable amphotericin B: mix-ups between lipid and non-lipid formulations.
Prescrire Int; 2009 Dec; 18(104):258-60. PubMed ID: 20025095
[TBL] [Abstract][Full Text] [Related]
3. Lipid formulations of amphotericins: are you a lumper or a splitter?
Wingard JR
Clin Infect Dis; 2002 Oct; 35(7):891-5. PubMed ID: 12228829
[No Abstract] [Full Text] [Related]
4. Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.
Frothingham R
Clin Infect Dis; 2002 Oct; 35(7):896-7; author reply 897-8. PubMed ID: 12228830
[No Abstract] [Full Text] [Related]
5. Amphotericin B use in children: conventional and lipid-based formulations.
Kuyucu N
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):357-67. PubMed ID: 21417875
[TBL] [Abstract][Full Text] [Related]
6. Lipid amphotericin B formulations as comparators in clinical trials.
Powers JH; Albrecht R
Clin Infect Dis; 2004 Jan; 38(2):305-6; author reply 306-7. PubMed ID: 14699471
[No Abstract] [Full Text] [Related]
7. Lipid formulations of polyene antifungal drugs and attenuation of associated nephrotoxicity.
Razzaque MS; Hossain MA; Ahsan N; Taguchi T
Nephron; 2001 Nov; 89(3):251-4. PubMed ID: 11598385
[TBL] [Abstract][Full Text] [Related]
8. Lipid-based antifungal agents: a concise overview.
Arikan S
Cell Mol Biol Lett; 2002; 7(3):919-22. PubMed ID: 12378276
[TBL] [Abstract][Full Text] [Related]
9. Amphotericin B: is a lipid-formulation gold standard feasible?
Spellberg B; Witt MD; Beck CK
Clin Infect Dis; 2004 Jan; 38(2):304-5; author reply 306-7. PubMed ID: 14699470
[No Abstract] [Full Text] [Related]
10. Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation.
Mohr JF; Hall AC; Ericsson CD; Ostrosky-Zeichner L
Pharmacotherapy; 2005 Mar; 25(3):426-8. PubMed ID: 15843289
[TBL] [Abstract][Full Text] [Related]
11. Amphotericin B, its lipid formulations and conjugates with polymers.
Kubicová L; Pravda M; Buchta V; Voprsalová M; Sedlák M
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S54-6. PubMed ID: 15141979
[TBL] [Abstract][Full Text] [Related]
12. What is the current and future status of conventional amphotericin B?
Kleinberg M
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
[TBL] [Abstract][Full Text] [Related]
13. [Lipid formulations of amphotericin].
Botero MC; Puentes-Herrera M; Cortés JA
Rev Chilena Infectol; 2014 Oct; 31(5):518-27. PubMed ID: 25491449
[TBL] [Abstract][Full Text] [Related]
14. Lipid formulations of amphotericin B. Less toxicity but at what economic cost?
Tollemar J; Ringdén O
Drug Saf; 1995 Oct; 13(4):207-18. PubMed ID: 8573294
[No Abstract] [Full Text] [Related]
15. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
16. Lipid formulations of amphotericin B.
Dix SP; Andriole VT
Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516
[TBL] [Abstract][Full Text] [Related]
17. Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B.
Barcia JP
Pharmacotherapy; 1998; 18(4):874-6. PubMed ID: 9692667
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a new formulation of amphotericin B in murine disseminated infections by Candida glabrata or Candida tropicalis.
Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
Int J Antimicrob Agents; 2009 Dec; 34(6):566-9. PubMed ID: 19733036
[TBL] [Abstract][Full Text] [Related]
19. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
[TBL] [Abstract][Full Text] [Related]
20. Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment.
Falci DR; dos Santos RP; Wirth F; Goldani LZ
Mycoses; 2011 Mar; 54(2):91-8. PubMed ID: 19878457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
